Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

TG Therapeutics: A Look At New Briumvi Data And Ocrevus Zunovo Approval [Seeking Alpha]

TG Therapeutics, Inc. (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
Company Research Source: Seeking Alpha
Play 11min Summary Shares of TG Therapeutics made new 52-week highs this week, helped in part by new Briumvi data presentations at ECTRIMS and despite Roche receiving FDA approval for Ocrevus Zunovo. Ocrevus Zunovo's convenience profile does not look threatening and Roche believes it represents an incremental growth opportunity, primarily in treatment centers where IV infusions are not possible. Convenience should also be the third consideration for patients, after efficacy and safety, and Briumvi's position on both still looks strong. The new Briumvi data at ECTRIMS reinforce that switching from other multiple sclerosis therapies is seamless, and that the IV infusion of Briumvi can be completed in 30 minutes. The focus now turns back to quarterly earnings updates from TG and its two key competitors. Looking for more investing ideas like this one? Get them exclusively at Growth Stock Forum. Learn More » mkurtbas/iStock via Getty Images Shares of TG Therapeutics NA Show less Read more
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for TGTX alerts
Opt-in for
TGTX alerts

from News Quantified
Opt-in for
TGTX alerts

from News Quantified